Insider speaks out against the FDA

Alosetron (Lotronex)a drug for irritable bowel syndromewas withdrawn from sale in the United States in late 2000 after reports of serious adverse events, but six weeks later the special joint advisory committee to the United States Food and Drug Administration (FDA) recommended its remarketing. A senior advisor from the committee has warned of more deaths if the drug is relaunched, and a former insider of the FDA says that the agency has become a servant of the pharmaceutical industry. On p 592 Moynihan charts the path of the drug and examines the truth or otherwise of inappropriate corporate influence in drug licensing.

(Credit: MARTY KATZ)

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.